Skye Bioscience, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Deficit and Redeemable Convertible Series B and Convertible Series C & D Preferred Stock (Tables)

Stockholders' Deficit and Redeemable Convertible Series B and Convertible Series C & D Preferred Stock (Tables)

6 Months Ended

Jun. 30, 2017

Schedule of warrants vested and outstanding

					Amount
	Exercise		Term		Issued and
Source	Price		(Years)		Outstanding

Pre 2015 Common Stock Warrants	$	1.00		6-10		4,000,000
2015 Common Stock Warrants	$	1.15-$5.00		5-10		442,000
2015 Series B Financing (see Note 6)
Common Stock Warrants to Series B Stockholders	$	0.25		5		6,250,000
Placement Agent Warrants	$	0.25		5		187,500
2016 Common Stock Warrants to Service Providers	$	1.15		10		40,000
2016 Series C Placement Agent Warrants	$	0.40		5		125,000
2017 Series D Placement Agent Warrants	$	0.25		5		480,000
2017 Common Stock Warrants to Service Providers	$	0.41		5		125,000

Total warrants vested and outstanding as of June 30, 2017						11,649,500

Schedule of summary of stock option activity

			Options Outstanding
								Weighted
	for Grant of							Average
	Options &		Number of			Price per		Exercise
	Shares		Shares			Share		Price
Balance at December 31, 2016		857,500		1,142,500		$	0.42-3.00	$	0.61
Options granted		-		-		$	-	$	-
Options exercised		-		-		$	-	$	-
Options cancelled		12,500		(12,500	)	$	1.15	$	1.15
Balance at June 30, 2017		870,000		1,130,000		$	0.42-3.00	$	0.60
Vested and Exercisable at June 30, 2017				452,000		$	0.42-3.00	$	0.60

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References + Details